Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin in children 3-24 months with fever and neutropenia
NCT00292071Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- May 2004
- Primary completion
- Jul 2006
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 2 trial of caspofungin in fungal infection, sponsored by Merck & Co.. Started May 2004; status: completed.
02
Drugs
caspofungin
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00292071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00292071.